Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00759031 · ClinicalTrials.gov registry record · Phase 3

Investigation of Dental Plaque and Gingival Index

A Phase 3 study, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
19
Enrollment target

NCT00759031: Completed Phase 3 study, sponsored by Colgate Palmolive.

NCT00759031 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 19 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00759031, a Phase 3 study, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
19 participants
Enrollment target

Study Summary

Investigation of inhibitory effect of prototype toothpaste on dental plaque formation via modified gingival margin plaque index method.

Primary Outcome

Scale 0 to 100% of tooth gingival margin covered by plaque. (0=no plaque, 100%=100% of the tooth's gingival margin is covered in plaque). The lower the score less dental plaque is present along the gum line and therefore the better the performance of the study treatment.

Interventions

  • DRUG Sodium Monofluorophosphate
  • DRUG Triclosan/Fluoride/Copolymer

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2008-02
Est. Completion 2008-03
Phase Phase 3
Colgate Palmolive

51 total trials

What the finished NCT00759031 record still lists

NCT00759031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Sodium Monofluorophosphate is the first listed.

NCT00759031 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00759031 about?

NCT00759031 is a clinical study titled "Investigation of Dental Plaque and Gingival Index". Investigation of inhibitory effect of prototype toothpaste on dental plaque formation via modified gingival margin plaque index method.

What is the current status of trial NCT00759031?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2008-02. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00759031?

The interventions under investigation include: Sodium Monofluorophosphate (DRUG), Triclosan/Fluoride/Copolymer (DRUG).

Who is sponsoring clinical trial NCT00759031?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00759031's enrollment target sits among peer trials

19 1969th of 2000 higher than 31 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00759031, the US trial registry maintained by the National Library of Medicine. NCT00759031 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.